Tribal Request for Reconsideration Hearing, 84608-84609 [2024-23441]
Download as PDF
84608
Federal Register / Vol. 89, No. 205 / Wednesday, October 23, 2024 / Notices
• By Mail: NIOSH Docket Office,
Robert A. Taft Laboratories, MS C–34,
1090 Tusculum Avenue, Cincinnati,
Ohio 45226–1998.
Instructions: All written submissions
received in response to this notice must
include the agency name (Centers for
Disease Control and Prevention, HHS)
and docket number (CDC–2024–0082;
NIOSH–354) for this action. All relevant
comments, including any personal
information provided, will be posted
without change to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Rachel Weiss, Program Analyst, 1090
Tusculum Avenue, MS: C–48,
Cincinnati, OH 45226; telephone (404)
498–2500 (this is not a toll-free
number); email NIOSHregs@cdc.gov.
Title I of
the James Zadroga 9/11 Health and
Compensation Act of 2010 (Zadroga
Act) (Pub. L. 111–347, as amended by
Pub. L. 114–113, Pub. L. 116–59, Pub.
L. 117–328, and Pub. L. 118–31), added
Title XXXIII to the Public Health
Service Act (PHS Act),1 establishing the
WTC Health Program within HHS. The
WTC Health Program provides medical
monitoring and treatment benefits for
health conditions on the List 2 to eligible
firefighters and related personnel, law
enforcement officers, and rescue,
recovery, and cleanup workers who
responded to the September 11, 2001,
terrorist attacks in New York City, at the
Pentagon, and in Shanksville,
Pennsylvania (responders). The Program
also provides benefits to eligible persons
who were present in the dust or dust
cloud on September 11, 2001, or who
worked, resided, or attended school,
childcare, or adult daycare in the New
York City disaster area (survivors).
The Zadroga Act also requires that the
Program conduct or support research on
health conditions that may result from
the September 11, 2001, terrorist
attacks, addressing the following topics:
• Physical and mental health
conditions that may be related to the
September 11, 2001, terrorist attacks;
• Diagnosing WTC-related health
conditions for which there have been
diagnostic uncertainty; and
khammond on DSKJM1Z7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
1 Title XXXIII of the PHS Act is codified at 42
U.S.C. 300mm–300mm–64. Those portions of the
Zadroga Act found in Titles II and III of Public Law
111–347 do not pertain to the WTC Health Program
and are codified elsewhere.
2 The List of WTC-Related Health Conditions is
established in 42 U.S.C. 300mm–22(a)(3)–(4) and
300mm–32(b); additional conditions may be added
through rulemaking and the complete List is
provided in WTC Health Program regulations at 42
CFR 88.15.
VerDate Sep<11>2014
18:48 Oct 22, 2024
Jkt 265001
• Treating WTC-related health
conditions for which there have been
treatment uncertainty.
For more information on NIOSHfunded research projects related to the
September 11, 2001, terrorist attacks,
and areas of interest based on the
Program’s Research Agenda, please visit
the WTC Health Program Research web
page (https://www.cdc.gov/wtc/
research.html).
(3) What emerging health conditions
that may be related to 9/11 exposure
should be prioritized and addressed?
John J. Howard,
Administrator, World Trade Center Health
Program and Director, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention, Department
of Health and Human Services.
[FR Doc. 2024–24486 Filed 10–22–24; 8:45 am]
BILLING CODE 4163–18–P
Request for Information
To further relevant WTC Health
Program research in FY2026, NIOSH has
forecasted two notices of funding
opportunities: (1) RFA–OH–26–001:
Cooperative Research Agreements
Related to the World Trade Center
Health Program (https://grants.gov/
search-results-detail/356163) and (2)
RFA–OH–26–002: Assessment and
Evaluation of Emerging Health
Conditions Relevant to the World Trade
Center Health Program (https://
grants.gov/search-results-detail/
356164).
NIOSH seeks to achieve a suitable mix
of meritorious research projects which
assess the feasibility of new ways to
enhance interventions and program
evaluations with the potential to
improve WTC Health Program treatment
and care, and the overall well-being of
9/11-exposed populations. Clinical
research areas of interest include
methods, interventions, or procedures
which can improve the screening,
diagnosis, and treatment of WTC-related
health conditions and care for those
exposed. NIOSH expects that such
clinical research outcomes will
incorporate relevant epidemiological
aspects and use research results to
improve treatment and care. Assessment
and evaluation of treatment and care
programs for WTC-related health
conditions and exposed populations are
also of interest. Additional details are
provided in the forecasts for these
proposed funding opportunities (please
refer to the links included in this
notice).
Specifically, NIOSH seeks input on
research priorities with regard to the
following questions:
(1) What are the primary research
needs for the 9/11-exposed population,
such as WTC responders, screeningeligible WTC survivors, or certifiedeligible WTC survivors?
(2) What are the primary health
concerns that are potentially related to
9/11 exposure, or the treatment thereof,
and how do they differ among groups
within the 9/11-exposed population?
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Tribal Request for Reconsideration
Hearing
Office of Child Care;
Administration for Children and
Families; U.S. Department of Health and
Human Services.
ACTION: Notice of request for
reconsideration hearing.
AGENCY:
Notice is hereby given to the
Inter-Tribal Council of Nevada (ITCN)
and interested parties of a
reconsideration hearing. The purpose of
the hearing is to reconsider the decision
of the Administration for Children and
Families (ACF), Office of Child Care
(OCC) regarding revision to the FY2023–
2025 triennial child count submitted by
the Inter-Tribal Council of Nevada
(ITCN) as part of their triennial plan,
submitted on July 1, 2022. Because the
child count was submitted as part of
ITCN’s FY2023–205 triennial plan,
ITCN is entitled to request
reconsideration to determine ‘‘whether
such Plan or amendment conforms to
the requirements for approval under the
Act and pertinent Federal regulations.’’
The sole issue to be reconsidered is
OCC’s decision to reduce ITCN’s child
count.
DATES: December 3, 2024, at 9:00 a.m.
PST; 12:00 EST.
ADDRESSES: Virtual via Zoom; Interested
parties must submit a request for a
registration link to Latasha Abney,
Director, ACF Office of Grants Policy
latasha.abney@acf.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Latasha Abney, Director, ACF Office of
Grants Policy latasha.abney@
acf.hhs.gov or (202) 401–5324.
SUPPLEMENTARY INFORMATION: By letter
dated January 17, 2023, OCC
communicated its decision that ITCN
had submitted a duplicated child count
in an area that overlapped the service
area of another CCDF tribal lead agency,
and that the area was not within a
SUMMARY:
E:\FR\FM\23OCN1.SGM
23OCN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 205 / Wednesday, October 23, 2024 / Notices
reasonably close geographic proximity
to the delineated borders of one of
ITCN’s member tribes, as required in 45
CFR 98.61(c) and 98.83(b), and as
described in the Program Instruction
CCDF–ACF–PI–2022–03. As a result,
OCC adjusted ITCN’s child count
downward.
CCDF regulations prescribe that
reconsideration shall be conducted by
hearing governed by 45 CFR part 99.
The ACF Director of Office of Grants
Policy, Latasha Abney, is the designated
presiding officer. The presiding officer
has authority to ‘‘modify or waive any
rule in [Part 99] upon determination
that no party will be unduly prejudiced
and the ends of justice will thereby be
served.’’ 45 CFR 99.4.
45 CFR 99.15 allows recognition of
other individuals or groups as parties ‘‘if
the issues to be considered at the
hearing have directly caused them
injury and their interests to be protected
by the governing Federal statute and
regulations.’’ This Federal Register
notice serves as notification to other
parties who may have interest in this
hearing. Individuals or groups desiring
to participate as parties should submit
a petition in writing to presiding officer,
Latasha Abney, at the address above
within 15 days of publication of this
notice. Such petition shall concisely
state (i) Petitioner’s interest in the
proceeding; (ii) Who will appear for
petitioner; (iii) The issues on which
petitioner wishes to participate; and (iv)
Whether petitioner intends to present
witnesses. A copy of the petition must
also be served on ITCN Executive
Director, Deserea Quintana at
dquintana@itcn.org. The presiding
officer will promptly determine whether
each petitioner has the requisite interest
and shall permit or deny participation
accordingly.
45 CFR 99.22 allows parties to (a)
Appear by counsel or other authorized
representative, in all hearing
proceedings; (b) Participate in any
prehearing conference held by the
presiding officer; (c) Agree to
stipulations as to facts which will be
made a part of the record; (d) Make
opening statements at the hearing; (e)
Present relevant evidence on the issues
at the hearing; (f) Present witnesses who
then must be available for crossexamination by all other parties; (g)
Present oral arguments at the hearing;
and (h) Submit written briefs, proposed
findings of fact, and proposed
conclusions of law, after the hearing. 45
CFR 99.23 allows that ‘‘The Department,
the Lead Agency, and any individuals or
groups recognized as parties shall have
the right to conduct discovery
(including depositions) against
VerDate Sep<11>2014
18:48 Oct 22, 2024
Jkt 265001
opposing parties,’’ and that Rules 26–37
of the Federal Rules of Civil Procedure
shall apply to discovery proceedings.
Pursuant to 45 CFR 99.32, at the
conclusion of the hearing and
completion of post-hearing briefs, if any,
the presiding officer shall certify the
record and provide recommended
finding and a proposed decision to the
Assistant Secretary. Any party will then
have 20 days to file exceptions and a
supporting brief or statement with the
Assistant Secretary. The decision of the
Assistant Secretary shall be the final
agency action on the matter.
All written material provided by ACF,
ITCN, and any other recognized party
will be included in the administrative
record.
Megan E. Steel,
ACF Certifying Officer. Administration for
Children and Families.
[FR Doc. 2024–23441 Filed 10–22–24; 8:45 am]
BILLING CODE 4184–87–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Notice of Interest Rate on Overdue
Debts
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 123⁄8%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended September 30,
2024. This rate is based on the Interest
Rates for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 254o(b)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
PO 00000
Frm 00089
Fmt 4703
Sfmt 9990
84609
debt until the Department of Health and
Human Services publishes a revision.
David C. Horn,
Director, Office of Financial Policy and
Reporting.
[FR Doc. 2024–24510 Filed 10–22–24; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Feasibility of Novel
Diagnostics for TB in Endemic Countries
(FEND for TB) (R01—Clinical Trial Not
Allowed).
Date: November 22, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E72A,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E72A, Rockville, MD
20892, (240) 669–5023, fdesilva@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24543 Filed 10–22–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\23OCN1.SGM
23OCN1
Agencies
[Federal Register Volume 89, Number 205 (Wednesday, October 23, 2024)]
[Notices]
[Pages 84608-84609]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23441]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Tribal Request for Reconsideration Hearing
AGENCY: Office of Child Care; Administration for Children and Families;
U.S. Department of Health and Human Services.
ACTION: Notice of request for reconsideration hearing.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given to the Inter-Tribal Council of Nevada
(ITCN) and interested parties of a reconsideration hearing. The purpose
of the hearing is to reconsider the decision of the Administration for
Children and Families (ACF), Office of Child Care (OCC) regarding
revision to the FY2023-2025 triennial child count submitted by the
Inter-Tribal Council of Nevada (ITCN) as part of their triennial plan,
submitted on July 1, 2022. Because the child count was submitted as
part of ITCN's FY2023-205 triennial plan, ITCN is entitled to request
reconsideration to determine ``whether such Plan or amendment conforms
to the requirements for approval under the Act and pertinent Federal
regulations.'' The sole issue to be reconsidered is OCC's decision to
reduce ITCN's child count.
DATES: December 3, 2024, at 9:00 a.m. PST; 12:00 EST.
ADDRESSES: Virtual via Zoom; Interested parties must submit a request
for a registration link to Latasha Abney, Director, ACF Office of
Grants Policy [email protected].
FOR FURTHER INFORMATION CONTACT: Latasha Abney, Director, ACF Office of
Grants Policy [email protected] or (202) 401-5324.
SUPPLEMENTARY INFORMATION: By letter dated January 17, 2023, OCC
communicated its decision that ITCN had submitted a duplicated child
count in an area that overlapped the service area of another CCDF
tribal lead agency, and that the area was not within a
[[Page 84609]]
reasonably close geographic proximity to the delineated borders of one
of ITCN's member tribes, as required in 45 CFR 98.61(c) and 98.83(b),
and as described in the Program Instruction CCDF-ACF-PI-2022-03. As a
result, OCC adjusted ITCN's child count downward.
CCDF regulations prescribe that reconsideration shall be conducted
by hearing governed by 45 CFR part 99. The ACF Director of Office of
Grants Policy, Latasha Abney, is the designated presiding officer. The
presiding officer has authority to ``modify or waive any rule in [Part
99] upon determination that no party will be unduly prejudiced and the
ends of justice will thereby be served.'' 45 CFR 99.4.
45 CFR 99.15 allows recognition of other individuals or groups as
parties ``if the issues to be considered at the hearing have directly
caused them injury and their interests to be protected by the governing
Federal statute and regulations.'' This Federal Register notice serves
as notification to other parties who may have interest in this hearing.
Individuals or groups desiring to participate as parties should submit
a petition in writing to presiding officer, Latasha Abney, at the
address above within 15 days of publication of this notice. Such
petition shall concisely state (i) Petitioner's interest in the
proceeding; (ii) Who will appear for petitioner; (iii) The issues on
which petitioner wishes to participate; and (iv) Whether petitioner
intends to present witnesses. A copy of the petition must also be
served on ITCN Executive Director, Deserea Quintana at
[email protected]. The presiding officer will promptly determine
whether each petitioner has the requisite interest and shall permit or
deny participation accordingly.
45 CFR 99.22 allows parties to (a) Appear by counsel or other
authorized representative, in all hearing proceedings; (b) Participate
in any prehearing conference held by the presiding officer; (c) Agree
to stipulations as to facts which will be made a part of the record;
(d) Make opening statements at the hearing; (e) Present relevant
evidence on the issues at the hearing; (f) Present witnesses who then
must be available for cross-examination by all other parties; (g)
Present oral arguments at the hearing; and (h) Submit written briefs,
proposed findings of fact, and proposed conclusions of law, after the
hearing. 45 CFR 99.23 allows that ``The Department, the Lead Agency,
and any individuals or groups recognized as parties shall have the
right to conduct discovery (including depositions) against opposing
parties,'' and that Rules 26-37 of the Federal Rules of Civil Procedure
shall apply to discovery proceedings.
Pursuant to 45 CFR 99.32, at the conclusion of the hearing and
completion of post-hearing briefs, if any, the presiding officer shall
certify the record and provide recommended finding and a proposed
decision to the Assistant Secretary. Any party will then have 20 days
to file exceptions and a supporting brief or statement with the
Assistant Secretary. The decision of the Assistant Secretary shall be
the final agency action on the matter.
All written material provided by ACF, ITCN, and any other
recognized party will be included in the administrative record.
Megan E. Steel,
ACF Certifying Officer. Administration for Children and Families.
[FR Doc. 2024-23441 Filed 10-22-24; 8:45 am]
BILLING CODE 4184-87-P